Additionally, the correlation of BET protein sub-members with various clinicopathological types was further investigated, including pathological grades (Table 1), clinical stages (Table 2), TP53 mutation (Table 3), and chemotherapy types (Table 4) of ovarian cancer patients. The gene discussed is TP53; the disease is ovarian carcinoma.